High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) TrialByJ. Sanford Schwartz, MD,Y. Richard Wang, MD, PhD,John G. F. Cleland, MD,Longlong Gao, MS,Mark Weiner, MD,Philip A. Poole-Wilson, MD,foJune 1st 2003
